FrancophonIA/ELRC3.0 huggingface dataset:
English: When they are given by an injection, tobramycin and other aminoglycoside antibiotics can cause harm to an unborn child, such as deafness.
Croatian: Kada se daju injekcijom, tobramicin i drugi aminoglikozidni antibiotici mogu naškoditi nerođenom djetetu, poput nastanka gluhoće.
English: Do not take the capsules out of the card in advance.
Croatian: Ne vadite unaprijed kapsule iz kartice.
English: Hearing loss and tinnitus were reported by patients in the TOBI Podhaler clinical studies (see section 4.8).
Croatian: Gubitak sluha i tinitus zabilježeni su u bolesnika u kliničkim ispitivanjima TOBI Podhalera (vidjeti dio 4.8).
English: Haemodialysis may be helpful in removing tobramycin from the body.
Croatian: Hemodijaliza može pomoći kod uklanjanja tobramicina iz tijela.
English: In the patients aged <20 years the increase from baseline percent predicted FEV1 was larger: 11.3% for TOBI Podhaler and 6.9% for the nebuliser solution after 3 cycles.
Croatian: U bolesnika u dobi od <20 godina, povećanje od početne vrijednosti postotka predviđenog FEV1 bilo je veće: 11,3% za TOBI Podhaler i 6,9% za otopinu za nebulizator nakon 3 ciklusa.
English: Hypersensitivity to the active substance and any aminoglycoside, or to any of the excipients listed in section 6.1.
Croatian: Preosjetljivost na djelatnu tvar i bilo koji aminoglikozid, ili neku od pomoćnih tvari navedenih u dijelu 6.1.
English: • The active substance is tobramycin.
Croatian: • Djelatna tvar je tobramicin.
English: Tobramycin is eliminated from the systemic circulation primarily by glomerular filtration of the unchanged compound.
Croatian: Tobramicin se eliminira iz sistemske cirkulacije u prvom redu glomerularnom filtracijom nepromijenjenog spoja.
English: • Do not use this medicine after the expiry date which is stated on the box or capsule card.
Croatian: • Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji ili kartici s kapsulama iza oznake „EXP“.
English: Because of the potential for ototoxicity and nephrotoxicity in infants, a decision should be made whether to terminate breast-feeding or discontinue treatment with TOBI Podhaler, taking into account the importance of the treatment to the mother.
Croatian: Zbog potencijalnog rizika od ototoksičnosti i nefrotoksičnosti u dojenčadi, mora se odlučiti hoće li se prekinuti dojenje ili liječenje TOBI Podhalerom, imajući u vidu važnost liječenja za majku.
English: • Never wash the Podhaler device with water.
Croatian: • Nikada ne perite uređaj Podhaler s vodom.
English: Observed benefits on lung function and P. aeruginosa suppression should be assessed in the context of the patient's tolerance of TOBI Podhaler.
Croatian: Uočene koristi za plućnu funkciju i supresiju P. aeruginosa moraju se procijeniti u kontekstu bolesnikove tolerancije na TOBI Podhaler.
English: Patients receiving concomitant parenteral aminoglycoside therapy (or any medication affecting renal excretion, such as diuretics) should be monitored as clinically appropriate taking into account the risk of cumulative toxicity.
Croatian: Druge mjere opreza Bolesnike koji primaju istodobnu terapiju parenteralnim aminoglikozidom (ili bilo kojim lijekom koji utječe na bubrežno izlučivanje, kao što su diuretici) treba pratiti na klinički primjeren način uzimajući u obzir rizik od kumulativne toksičnosti.
English: In the active-controlled study, at least 89% of patients had P. aeruginosa isolates with MICs at least 15 times lower than mean post-dose sputum concentration, both at baseline and at the end of the third active treatment cycle.
Croatian: U aktivno kontroliranom ispitivanju najmanje 89% bolesnika imalo je izolate P. aeruginosa s MIK-ovima koji su bili najmanje 15 puta niži od srednje koncentracije u sputumu nakon doze, kako na početku ispitivanja tako i na kraju trećeg ciklusa aktivne terapije.
English: Should cough remain unchanged, other antibiotics should be considered.
Croatian: Ako ne dođe do promjene u kašlju, potrebno je razmotriti druge antibiotike.
English: No interaction studies have been performed with TOBI Podhaler.
Croatian: Nisu provedena ispitivanja interakcija s TOBI Podhalerom.
English: Immediately insert the capsule into the inhaler chamber.
Croatian: Odmah umetnite kapsulu u komoru inhalatora.
English: After a few normal breaths away from the inhaler, perform a second inhalation from the same capsule.
Croatian: Nakon nekoliko normalnih udisaja i izdisaja dalje od inhalatora, obavite drugu inhalaciju iz iste kapsule.
English: These may still happen while taking TOBI Podhaler, but should not be any more frequent or seem worse than before.
Croatian: Podhaler, ali ne bi smjeli biti učestaliji ili gori nego ranije.
English: These medicines may harm the kidneys.
Croatian: Ovi lijekovi mogu naštetiti bubrezima.
English: Subcutaneous administration of tobramycin did not affect mating behaviour or cause impairment of fertility in male or female rats.
Croatian: Supkutana primjena tobramicina nije utjecala na reproduktivno ponašanje ili uzrokovala narušavanje plodnosti u ženki ili mužjaka štakora.
English: Urea and creatinine levels should be reassessed after every 6 complete cycles of TOBI Podhaler therapy.
Croatian: Vrijednosti uree i kreatinina treba ponovno provjeriti nakon svakih 6 dovršenih ciklusa terapije TOBI Podhalerom.
English: Suppression of sputum P. aeruginosa density was similar across age groups in both arms.
Croatian: Supresija gustoće P. aeruginosa u sputumu bila je slična uz svim dobnim grupama u obje skupine.
English: Store in the original package in order to protect from moisture and only remove immediately before use.
Croatian: Čuvati u originalnom pakiranju radi zaštite od vlage i izvaditi tek neposredno prije uporabe.
English: It is important that you keep using the product twice each day during your 28 days on treatment and that you keep to the 28-day on, 28-day off cycle.
Croatian: Važno je da nastavite uzimati lijek dvaput na dan tijekom 28 dana liječenja te da se pridržavate ciklusa
English: TOBI Podhaler has no or negligible influence on the ability to drive and use machines.
Croatian: TOBI Podhaler ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: The clinical significance of changes in MICs of tobramycin for P. aeruginosa has not been clearly established in the treatment of cystic fibrosis patients.
Croatian: Klinički značaj promjena MIK-ova tobramicina za P. aeruginosa nije jasno utvrđen u liječenju bolesnika s cističnom fibrozom.
English: 56 capsules and 1 inhaler
Croatian: 56 kapsula i 1 inhalator
English: The dose of TOBI Podhaler is the same for all patients within the approved age range, regardless of age or weight.
Croatian: Podhalera jednaka je za sve bolesnike u odobrenom dobnom rasponu, bez obzira na dob ili tjelesnu težinu.
English: These medicines may cause muscle weakness to appear or become worse..
Croatian: Ovi lijekovi mogu uzrokovati pojavu ili pogoršanje slabosti mišića.
English: The serum concentration of tobramycin should only be monitored through validated methods.
Croatian: Koncentracija tobramicina u serumu smije se kontrolirati samo pomoću validiranih metoda.
English: Do not use TOBI Podhaler capsules with any other device, and do not use the Podhaler device to take any other medicine.
Croatian: Podhaler kapsule s bilo kojim drugim uređajem i ne koristite uređaj Podhaler s bilo kojim drugim lijekom.
English: Do not swallow.
Croatian: Ne gutati.
English: TOBI Podhaler is taken in alternating cycles of 28 days on treatment followed by 28 days off treatment.
Croatian: TOBI Podhaler se uzima u naizmjeničnim ciklusima od 28 dana uzimanja terapije, nakon čega slijedi 28 dana neuzimanja terapije.
English: If you are taking tobramycin or another aminoglycoside antibiotic by injection, it can sometimes cause hearing loss, dizziness and kidney damage.
Croatian: Ako uzimate tobramicin ili neki drugi aminoglikozidni antibiotik putem injekcije, to ponekad može uzrokovati gubitak sluha, omaglicu i oštećenje bubrega.
English: • Always hold the device with the mouthpiece pointing down when piercing the capsule.
Croatian: • Uvijek držite uređaj s nastavkom za usta okrenutim prema dolje kada bušite kapsulu.
English: Systemic exposure following inhalation of TOBI Podhaler is very low, however TOBI Podhaler should not be used during pregnancy unless clearly necessary, i.e. when the benefits to the mother outweigh the risks to the foetus.
Croatian: Podhalera vrlo je niska, međutim TOBI Podhaler se ne smije koristiti tijekom trudnoće osim ako to nije neophodno, tj. kada koristi za majku premašuju rizike za plod.
English: • Unusual difficulty in breathing with wheezing or coughing and chest tightness (common).
Croatian: • Neuobičajene poteškoće u disanju uz piskanje ili kašalj i stezanje u prsnom košu (često).
English: The European Medicines Agency has waived the obligation to submit the results of studies with TOBI Podhaler in one or more subsets of the paediatric population in treatment of pseudomonas aeruginosa pulmonary infection/colonisation in patients with cystic fibrosis (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja lijeka TOBI Podhaler u jednoj ili više podskupina pedijatrijske populacije u liječenju plućne infekcije uzrokovane bakterijom Pseudomonas aeruginosa/kolonizacije u bolesnika s cističnom fibrozom (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: 4.7 Effects on ability to drive and use machines
Croatian: 4.7 Utjecaj na sposobnost upravljanja vozilima i rada sa strojevima TOBI
English: Carcinogenicity studies with inhaled tobramycin do not increase the incidence of any variety of tumour.
Croatian: Ispitivanja kancerogenosti s inhalacijskim tobramicinom ne ukazuju na povećanu incidenciju bilo koje vrste tumora.
English: Please read the following instructions carefully to learn how to use and care for your Podhaler device.
Croatian: UPUTE ZA UPORABU UREĐAJA PODHALER Pažljivo pročitajte upute u nastavku kako biste znali kako treba koristiti i čuvati Vaš Podhaler uređaj.
English: The capsules should remain in the capsule card until you need to use them.
Croatian: Kapsule moraju ostati u kartici s kapsulama dok ih ne trebate primijeniti.
English: • Take a few normal breaths away from the inhaler.
Croatian: • Napravite nekoliko normalnih udisaja dalje od inhalatora.
English: Remove inhaler from mouth, and hold breath for approximately 5 seconds, then exhale normally away from the inhaler.
Croatian: Izvadite inhalator iz usta i držite dah otprilike 5 sekundi, a zatim normalno izdahnite dalje od inhalatora.
English: Tobramycin serum concentrations may be helpful in monitoring overdosage.
Croatian: Koncentracije tobramicina u serumu mogu pomoći u praćenju predoziranja.
English: The improvements in lung function achieved during the first treatment cycle were maintained during the two subsequent cycles of treatment with TOBI Podhaler.
Croatian: Poboljšanja plućne funkcije postignuta tijekom prvog ciklusa liječenja održala su se tijekom naredna dva ciklusa liječenja TOBI Podhalerom.
English: Then breathe out normally, away from the inhaler.
Croatian: Zatim normalno izdahnite, dalje od inhalatora.
English: The recommended dose is 112 mg tobramycin (4 x 28 mg capsules), administered twice daily for 28 days.
Croatian: Preporučena doza je 112 mg tobramicina (4 x 28 mg kapsule), koja se primjenjuje dvaput na dan tijekom 28 dana.
English: • Cough, productive cough, voice alteration (hoarseness)
Croatian: • Kašalj, kašalj uz iskašljavanje sadržaja, promjenu glasa (promuklost)
English: Patients with haemoptysis (>60 ml) were excluded from the clinical studies so no data exist on the use of TOBI Podhaler in these patients.
Croatian: Bolesnici s hemoptizom (>60 ml) bili su isključeni iz kliničkih ispitivanja, pa ne postoje podaci o primjeni TOBI
English: In a 6-month (3 treatment cycles) study of TOBI Podhaler versus tobramycin nebuliser solution, which included a majority of tobramycin-experienced adult patients with chronic pulmonary P. aeruginosa infection, the suppression of sputum P. aeruginosa density was similar across age groups in both arms; however the increase from baseline FEV1 was larger in younger age groups (6 - <20) than in the adult subgroup (20 years and older) in both arms.
Croatian: U 6-mjesečnom (3 ciklusa liječenja) ispitivanju TOBI Podhalera u usporedbi s tobramicin otopinom za nebulizator, koje je uključivalo većinu odraslih bolesnika koji su imali iskustva s tobramicinom i kroničnu plućnu infekciju bakterijom P. aeruginosa, supresija gustoće P. aeruginosa u sputumu bila je slična u različitim dobnim grupama u obje skupine; međutim, povećanje u odnosu na početnu vrijednost FEV1 bilo je veće u mlađim dobnim grupama (6 - <20) nego u odrasloj grupi (20 godina i stariji) u obje terapijske skupine.
English: TOBI Podhaler is a powder for inhalation that is filled into capsules.
Croatian: TOBI Podhaler je prašak za inhalaciju koji se nalazi u kapsulama.
English: In case of signs of acute toxicity, immediate withdrawal of TOBI Podhaler and testing of renal function are recommended.
Croatian: U slučaju znakova akutne toksičnosti, preporučuje se hitno prekidanje primjene TOBI Podhalera i ispitivanje bubrežne funkcije.
English: The extent of systemic exposure (AUC) was also similar for the 112 mg TOBI Podhaler dose and the 300 mg tobramycin nebuliser solution dose.
Croatian: Razmjer sistemske izloženosti (AUC) bio je također sličan za dozu od 112 mg TOBI Podhalera i za dozu od 300 mg tobramicin otopine za nebulizator.
English: If the capsule is punctured but still contains some powder, place it back into the inhaler and take another two inhalations from the capsule.
Croatian: Ako je kapsula probušena, ali još uvijek sadrži nešto praška, vratite je u inhalator i napravite još dvije inhalacije iz kapsule.
English: Haemoptysis is a complication in cystic fibrosis and is more frequent in adults.
Croatian: Hemoptiza je komplikacija kod cistične fibroze i učestalija je u odraslih osoba.
English: Treatment with TOBI Podhaler for 28 days resulted in a statistically significant reduction in P. aeruginosa sputum density (mean difference with placebo about 2.70 log10 in colony forming units/CFUs).
Croatian: Liječenje TOBI Podhalerom tijekom 28 dana rezultiralo je statistički značajnim smanjenjem gustoće P. aeruginosa u sputumu (srednja razlika s placebom oko 2,70 log10 jedinica koje tvore kolonije/CFU (eng. colony forming unit)).
English: If you experience any of these, stop taking TOBI Podhaler and tell your doctor straight away.
Croatian: Ako osjetite bilo što od toga, prestanite uzimati TOBI Podhaler i odmah se obratite svom liječniku.
English: Fully exhale away from the inhaler.
Croatian: Potpuno izdahnite dalje od inhalatora.
English: In clinical studies, patients receiving TOBI Podhaler continued to take dornase alfa, bronchodilators, inhaled corticosteroids and macrolides, no evidence of drug interactions with these medicines was identified.
Croatian: Podhaler i nastavili uzimati alfa dornazu, bronhodilatatore, inhalacijske kortikosteroide i makrolide nisu pronađeni dokazi interakcija s tim lijekovima.
English: Ototoxicity, manifested as both auditory toxicity (hearing loss) and vestibular toxicity, has been reported with parenteral aminoglycosides.
Croatian: Ototoksičnost, koja se manifestira kao auditivna toksičnost (gubitak sluha) i kao vestibularna toskičnost, zabilježena je vezano uz primjenu parenteralnih aminoglikozida.
English: • Always keep the capsules in the capsule card until when you need to use them.
Croatian: • Uvijek držite kapsule u kartici s kapsulama do trenutka kada ih trebate upotrijebiti.
English: Adverse drug reactions in Table 1 are listed according to system organ classes in MedDRA.
Croatian: Nuspojave u Tablici 1 navedene su prema klasifikaciji organskih sustava MedDRA-e.
English: Treatment with TOBI Podhaler should be continued on a cyclical basis for as long as the physician considers the patient is gaining clinical benefit from the treatment with TOBI Podhaler.
Croatian: Liječenje TOBI Podhalerom treba nastaviti ciklički dokle god liječnik smatra da bolesnik ima kliničke koristi od liječenja TOBI Podhalerom.
English: Your doctor will supervise your first dose of TOBI Podhaler and check your lung function before and after dosing.
Croatian: Liječnik će nadzirati Vašu prvu dozu TOBI Podhalera i provjeriti
English: As tobramycin is not metabolised, an effect of hepatic impairment on the exposure to tobramycin is not expected.
Croatian: Budući da se tobramicin ne metabolizira, ne očekuje se utjecaj oštećenja jetre na izloženost tobramicinu.
English: • hearing problems (including noises in the ears and dizziness)
Croatian: • poteškoće sa sluhom (uključujući zvukove u ušima i omaglicu) • poteškoće s bubrezima
English: If you are taking one or more of the above medicines, discuss with your doctor before you take TOBI Podhaler.
Croatian: Ako uzimate jedan ili više gore navedenih lijekova, razgovarajte sa svojim liječnikom prije nego uzmete TOBI Podhaler.
English: Serum concentrations
Croatian: Koncentracije u serumu
English: In children under 13 years of age, discontinuations were more frequent in the TOBI nebuliser solution arm whereas in patients aged 13 to 19, discontinuation rates with both formulations were similar.
Croatian: U djece mlađe od 13 godina prekidi su bili učestaliji u skupini koja je primala TOBI otopinu za nebulizator, dok su među bolesnicima u dobi od 13 do 19 godina stope prekida bile slične za obje formulacije.
English: 1 reserve inhaler inside.
Croatian: Sadrži 1 rezervni inhalator.
English: Holding the body of the inhaler, unscrew and remove the mouthpiece from the inhaler body.
Croatian: Držeći tijelo inhalatora, odvijte i maknite nastavak za usta s tijela inhalatora.
English: In patients with any evidence of auditory dysfunction, or those with a predisposing risk, it may be necessary to consider audiological assessment before initiating TOBI Podhaler therapy.
Croatian: U bolesnika s bilo kojim dokazom auditivne disfunkcije, ili u onih s predisponirajućim rizikom, treba razmotriti audiološku obradu prije početka terapije TOBI Podhalerom.
English: TOBI Podhaler is used in patients aged 6 years and older who have cystic fibrosis to treat lung infections caused by bacteria called Pseudomonas aeruginosa.
Croatian: TOBI Podhaler se koristi u bolesnika u dobi od 6 i više godina koji imaju cističnu fibrozu, za liječenje plućnih infekcija uzrokovanih bakterijom koje se zove Pseudomonas aeruginosa.
English: In the absence of conventional susceptibility breakpoints for the inhaled route of administration, caution must be exercised in defining organisms as susceptible or insusceptible to inhaled tobramycin.
Croatian: U nedostatku konvencionalnih granica osjetljivosti kod inhalacijske primjene, moraju se primijeniti mjere opreza kod definiranja organizama kao osjetljivih ili neosjetljivih na inhalirani tobramicin.
English: No studies have been performed on patients with hepatic impairment.
Croatian: Nisu obavljena ispitivanja u bolesnika s oštećenjem jetre.
English: If an allergic response is suspected, TOBI Podhaler should be discontinued.
Croatian: Ako postoji sumnja na alergijsku reakciju, uzimanje TOBI Podhalera mora se prekinuti.
English: Bronchospasm should be treated as medically appropriate.
Croatian: Bronhospazam se mora liječiti na klinički primjeren način.
English: • Hold the inhaler with the mouthpiece pointing down
Croatian: • Držite inhalator s nastavkom za usta okrenutim prema dolje
English: Patients who use TOBI Podhaler during pregnancy, or become pregnant while taking TOBI Podhaler, should be informed of the potential hazard to the foetus.
Croatian: Podhaler tijekom trudnoće, ili koje zatrudne dok uzimaju TOBI Podhaler, moraju biti obaviještene o potencijalnoj opasnosti za plod.
English: Patients who were randomised to the placebo treatment group received placebo during the first treatment cycle and TOBI Podhaler in the subsequent two cycles.
Croatian: Bolesnici koji su bili randomizacijom dodijeljeni u placebo terapijsku skupinu primali su placebo tijekom prvog terapijskog ciklusa, te TOBI Podhaler u naredna dva ciklusa.
English: Over half of the patients in both the TOBI Podhaler and TOBI nebuliser solution treatment groups received new (additional) anti-pseudomonal antibiotics (64.9% and 54.5% respectively, the difference consisting mainly of oral ciprofloxacin use).
Croatian: Više od polovice bolesnika i u terapijskoj skupini koja je primala TOBI Podhaler i u skupini koja je primala TOBI otopinu za nebulizator primilo je nove (dodatne) antipseudomonalne antibiotike (64,9% odnosno 54,5%, razlika se sastojala uglavnom od peroralne primjene ciproflaksacina).
English: It is not known whether inhaling this medicine when you are pregnant causes side effects.
Croatian: Nije poznato uzrokuje li inhalacija ovog lijeka kada ste trudni nuspojave.
English: Inhaling medicines can also cause cough and this can happen with TOBI Podhaler.
Croatian: Inhalacija lijekova može uzrokovati i kašalj, a to se može dogoditi i s TOBI Podhalerom.
English: Contents of the pack and other information What TOBI Podhaler contains
Croatian: Sadržaj pakiranja i druge informacije Što TOBI
English: TOBI Podhaler capsules must always be stored in the blister (capsule card), and only removed immediately before use.
Croatian: TOBI Podhaler kapsule moraju se uvijek čuvati u blisteru (kartici s kapsulama) i izvaditi tek neposredno prije primjene.
English: What you need to know before you take TOBI Podhaler Do not take TOBI Podhaler
Croatian: Što morate znati prije nego počnete uzimati TOBI Podhaler Nemojte uzimati TOBI Podhaler
English: Inspect the used capsule.
Croatian: Provjerite upotrijebljenu kapsulu.
English: Safety and efficacy have not been studied in patients with forced expiratory volume in 1 second (FEV1) <25% or >75% predicted, or patients colonised with Burkholderia cepacia.
Croatian: 1 sekundi (FEV1) <25% ili >75% predviđenog, ili u bolesnika koloniziranih bakterijom Burkholderia cepacia.
English: • unusual difficulty in breathing with wheezing or coughing, chest tightness
Croatian: • neuobičajene poteškoće pri disanju uz piskanje ili kašalj, stezanje u prsnom košu
English: Treatment with both TOBI Podhaler and tobramycin 300 mg/5 ml nebuliser solution (TOBI) resulted in relative increases from baseline to day 28 of the third treatment cycle in percent predicted FEV1 of 5.8% and 4.7%, respectively.
Croatian: Liječenje TOBI Podhalerom i tobramicin 300 mg/5 ml otopinom za nebulizator (TOBI) rezultiralo je relativnim povećanjem od početne vrijednosti do 28. dana trećeg ciklusa terapije u postotku predviđenog FEV1 od 5,8% odnosno 4,7%.
English: The TOBI Podhaler Phase III clinical development programme consisted of two studies and 612 treated patients with a clinical diagnosis of CF, confirmed by quantitative pilocarpine iontophoresis sweat chloride test or well-characterised disease causing mutations in each cystic fibrosis transmembrane regulator (CFTR) gene, or abnormal nasal transepithelial potential difference characteristic of CF.
Croatian: Podhalera sastojao se od dva ispitivanja i 612 liječenih bolesnika s kliničkom dijagnozom CF-a, potvrđenom kvantitativnom pilokarpinskom iontoforezom za određivanje klorida u znoju ili dobro karakteriziranim mutacijama koje uzrokuju bolest u svakom genu za cistično-fibrozni transmembranski regulator provodljivosti (CFTR), ili abnormalnim električnim potencijalom nosne sluznice karakterističnim za CF.
English: TOBI Podhaler inhalation powder, hard capsules consist of a white to almost white powder for inhalation filled into clear colourless hard capsules with “NVR AVCI” imprinted in blue ink on one part of the capsule and the Novartis logo imprinted in blue on the other part of the capsule.
Croatian: TOBI Podhaler prašak inhalata, tvrde kapsule sastoji se od bijelog do gotovo bijelog praška za inhalaciju kojim su napunjene prozirne, bezbojne, tvrde kapsule s oznakom „NVR AVCI“ otisnutom plavom bojom na jednom dijelu kapsule i Novartisovim logotipom otisnutim plavom bojom na drugom dijelu kapsule.